You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
APPLYING RISK ASSESSMENT FOR STERILE PHARMACEUTICAL PRODUCTS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-FDP-006
- By: AKSU, Buket (Altınbaş University, Pharmaceutical Technology, Turkey)
- Co-author(s): Gizem Yeğen: Pharmaceutical Technology, Altınbaş University, ıstanbul, Turkey
Cansu Vatansever: Pharmaceutical Microbiology, Altınbaş University, ıstanbul, Turkey
Buket Aksu: Pharmaceutical Technology, Altınbaş University, ıstanbul, Turkey - Abstract:
Background
Pharmaceutical compound are sensitive to contamination during manufacturing and also usage periods (1). Some medical products such as injections, ophthalmic preparations, dialysis solutions must be sterile for prevent the microbial degradation and infection development. Steril products must not contain any type of microorganisms (2).Metho..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026